Patisiran for treating hereditary transthyretin amyloidosis

Supporting evidence

• Evaluation report

• Evaluation consultation committee papers (PDF 6.72 MB)

  Published:

  14 August 2019

• Final evaluation determination committee papers 1 (PDF 954 KB)

  Published:

  14 August 2019

• Final evaluation determination committee papers 2 (PDF 912 KB)

  Published:

  14 August 2019